Spots Global Cancer Trial Database for Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
Official Title: Development and Evaluation of a Therapeutic Education Intervention Focused on the Accession of Patients Treated With Hormonal Therapy in the Management of Breast Cancer: PEPs Hormonotherapy
Study ID: NCT02300675
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the feasibility and the effectiveness of a patient education program on patients' adherence to adjuvant hormone therapy (anti-estrogen or aromatase inhibitors) for breast cancer, in collaboration with teams of sociologists, patient education and medical oncologists.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
CH Lyon Sud, Pierre Bénite, , France
Hôpital Privé de la Loire, Saint-Etienne, , France
Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez, , France
Contact Details
Name: Aurélie Bourmaud, MD
Affiliation: Institut de Cancérologie de la Loire
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
